Appaloosa LP’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-695,000
Closed -$123M 41
2020
Q1
$123M Sell
695,000
-600,000
-46% -$113M 3.76% 7
2019
Q4
$248M Hold
1,295,000
6.22% 6
2019
Q3
$218M Hold
1,295,000
6.38% 6
2019
Q2
$217M Sell
1,295,000
-1,838,864
-59% -$255M 2.34% 7
2019
Q1
$459M Buy
3,133,864
+1,983,864
+173% +$288M 13.15% 2
2018
Q4
$154M Sell
1,150,000
-842,591
-42% -$138M 7.6% 3
2018
Q3
$380M Sell
1,992,591
-1,397,409
-41% -$257M 6.67% 3
2018
Q2
$565M Sell
3,390,000
-310,000
-8% -$49.8M 6.43% 3
2018
Q1
$623M Buy
3,700,000
+234,138
+7% +$39.3M 6.41% 4
2017
Q4
$567M Buy
3,465,862
+1,577,674
+84% +$283M 5.28% 7
2017
Q3
$387M Sell
1,888,188
-621,431
-25% -$145M 5.44% 5
2017
Q2
$610M Sell
2,509,619
-427,502
-15% -$100M 9.05% 1
2017
Q1
$702M Sell
2,937,121
-1,324,285
-31% -$308M 11.53% 1
2016
Q4
$895M Buy
4,261,406
+3,043,097
+250% +$630M 15.87% 1
2016
Q3
$281M Sell
1,218,309
-42,500
-3% -$10.4M 6.37% 5
2016
Q2
$291M Buy
1,260,809
+981,700
+352% +$226M 7.66% 4
2016
Q1
$74.8M Buy
+279,109
New +$79.9M 1.32% 26

Other funds holding AGN

Appaloosa LP's AGN Position: Q2 2020 in Review

Appaloosa LP sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 695,000 shares — an estimated $123M sold.

Appaloosa LP first reported a position in AGN in Q1 2016 and held it in 17 quarters. The position peaked at $895M in Q4 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Appaloosa LP reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Appaloosa LP sold 695,000 Allergan plc shares in Q2 2020, an estimated $123M.
  • Appaloosa LP first reported a position in Allergan plc in Q1 2016 and held it in 17 quarters.
  • Appaloosa LP's Allergan plc position peaked at $895M in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Appaloosa LP's 13F filing for Q2 2020, filed 14 Aug 2020.